Plasma exchange for children with autoimmune encephalitis
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests whether plasma exchange (a procedure that cleans the blood) can help children with a severe form of autoimmune encephalitis—a condition where the immune system attacks the brain. It's for children who haven't gotten better with standard treatments like steroids or IVIG.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have been diagnosed with autoimmune encephalitis within the last 3 months.
- They should have symptoms like new brain problems, seizures, or abnormal test results from spinal fluid or MRI.
- The treatment team must have decided that plasma exchange is needed, meaning the disease is severe or hasn't improved with steroids or IVIG.
- Your child's blood pressure and heart function must be stable enough for the procedure.
- Bleeding risks (like very low platelets or high INR) must be corrected before starting.
- Your child must not be enrolled in another research study that could interfere with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called efgartigimod to treat autoimmune encephalitis (AIE)—a rare condition where the immune system attacks the brain. The study enrolls children 12+ and adults to see if this drug can reduce symptoms and help recovery.
This trial tests whether removing harmful substances from the blood (plasma exchange) can help children with severe infections that cause organ failure or very low blood pressure. If your child is in the hospital with severe sepsis or septic shock and is between 1 month and 18 years old, this treatment might be an option.
This study looks at whether removing and replacing blood plasma (called therapeutic plasma exchange or TPE) can help people with immune-related nerve or brain conditions. It includes both new and returning cases that meet standard guidelines for this treatment.
This trial tests whether a procedure called therapeutic plasma exchange (TPE) — which cleans harmful substances from your blood — is more effective than standard medicines for treating severe autoimmune hepatitis. It may be an option if your condition is very serious and you are not able to get a liver transplant within the next month.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
This study looks back at kids aged 1–18 who had a treatment called therapeutic plasma exchange (TPE) in the pediatric kidney unit. TPE is a procedure that replaces the liquid part of the blood, which may help with certain kidney conditions.
Hear when a new Autoimmune Encephalitis (AE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.